Five-year subgroup analysis of tafasitamab plus lenalidomide from the phase II L-MIND study in patients with relapsed or refractory diffuse large B-cell lymphoma

被引：0
|
作者：
Duell, Johannes
Abrisqueta, Pau
Dreyling, Martin H.
Gaidano, Gianluca
Barca, Eva Gonzalez
Jurczak, Wojciech
Maddocks, Kami J.
Menne, Tobias
Tournilhac, Olivier
Bakuli, Abhishek
Amin, Aasim
Gurbanov, Konstantin
Salles, Gilles A.
Nagy, Zsolt
机构：
[1] Univ Klin Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Vall Hebron Univ Hosp, Dept Hematol, Vall Hebron Inst Oncol VHIO, Barcelona, Spain
[3] Ludwig Maximilians Univ Hosp, Munich, Germany
[4] Univ Piemonte Orientale, Div Hematol, Dept Translat Med, Novara, Italy
[5] Univ Barcelona, Inst Catal Oncol, Hosp Duran Reynals, IDIBELL, Barcelona, Spain
[6] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Krakow, Poland
[7] Ohio State Univ Wexner Med Ctr, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH USA
[8] Newcastle Tyne Hosp, Freeman Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[9] CHU Clermont Ferrand, Clermont Ferrand, France
[10] MorphoSys AG, Planegg, Germany
[11] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[12] Semmelweis Univ, Budapest, Hungary
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19522
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Five-Year Subgroup Analysis of Tafasitamab plus Lenalidomide From the Phase II L-MIND Study in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Duell, Johannes
    Abrisqueta, Pau
    Dreyling, Martin
    Gaidano, Gianluca
    Gonzalez Barca, Eva
    Jurczak, Wojciech
    Maddocks, Kami J.
    Menne, Tobias
    Nagy, Zsolt
    Tournilhac, Olivier
    Bakuli, Abhishek
    Amin, Aasim
    Gurbanov, Konstantin
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S436 - S437
  • [2] Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Duell, Johannes
    Maddocks, Kami J.
    Gonzalez-Barca, Eva
    Jurczak, Wojciech
    Liberati, Anna Marina
    de Vos, Sven
    Nagy, Zsolt
    Obr, Ales
    Gaidano, Gianluca
    Abrisqueta, Pau
    Andre, Marc
    Dreyling, Martin
    Menne, Tobias F.
    Dirnberger-Hertweck, Maren
    Weirather, Johannes
    Ambarkhane, Sumeet
    Salles, Gilles A.
    BLOOD, 2019, 134
  • [3] Five-Year Efficacy and Safety of Tafasitamab in Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results From the Phase II L-MIND Study
    Duell, Johannes
    Abrisqueta, Pau
    Andre, Marc
    Augustin, Marinela
    Gaidano, Gianluca
    Gonzalez Barca, Eva
    Jurczak, Wojciech
    Kalakonda, Nagesh
    Liberati, Anna Marina
    Maddocks, Kami J.
    Menne, Tobias
    Nagy, Zsolt
    Tournilhac, Olivier
    Bakuli, Abhishek
    Amin, Aasim
    Gurbanov, Konstantin
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S433 - S434
  • [4] Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
    Duell, J.
    Gonzalez-Barca, E.
    Augustin, M.
    Jurczak, W.
    Liberati, A. M.
    de Vos, S.
    Nagy, Z.
    Obr, A.
    Gaidano, G.
    Abrisqueta, P.
    Kalakonda, N.
    Andre, M.
    Menne, T.
    Tournilhac, O.
    Waltl, E. E.
    Dirnberger-Hertweck, M.
    Weirather, J.
    Maddocks, K. J.
    Ambarkhane, S.
    Dreyling, M.
    Salles, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 63 - 64
  • [5] Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Salles, Gilles
    Duell, Johannes
    Gonzalez-Barca, Eva
    Jurczak, Wojciech
    Liberati, Anna Marina
    de Vos, Sven
    Nagy, Zsolt
    Obr, Ales
    Gaidano, Gianluca
    Abrisqueta, Pau
    Kalakonda, Nagesh
    Andre, Marc
    Dreyling, Martin
    Menne, Tobias
    Tournilhac, Olivier
    Augustin, Marinela
    Dirnberger-Hertweck, Maren
    Weirather, Johannes
    Ambarkhane, Sumeet
    Maddocks, Kami J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S267 - S268
  • [6] Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
    Duell, Johannes
    Maddocks, Kami J.
    Gonzalez-Barca, Eva
    Jurczak, Wojciech
    Liberati, Anna Marina
    de Vos, Sven
    Nagy, Zsolt
    Obr, Ales
    Gaidano, Gianluca
    Abrisqueta, Pau
    Kalakonda, Nagesh
    Andre, Marc
    Dreyling, Martin
    Menne, Tobias
    Tournilhac, Olivier
    Augustin, Marinela
    Rosenwald, Andreas
    Dirnberger-Hertweck, Maren
    Weirather, Johannes
    Ambarkhane, Sumeet
    Salles, Gilles
    HAEMATOLOGICA, 2021, 106 (09) : 2417 - 2426
  • [7] Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
    Salles, Gilles
    Duell, Johannes
    Gonzalez Barca, Eva
    Tournilhac, Olivier
    Jurczak, Wojciech
    Liberati, Anna Marina
    Nagy, Zsolt
    Obr, Ales
    Gaidano, Gianluca
    Andre, Marc
    Kalakonda, Nagesh
    Dreyling, Martin
    Weirather, Johannes
    Dirnberger-Hertweck, Maren
    Ambarkhane, Sumeet
    Fingerle-Rowson, Gunter
    Maddocks, Kami
    LANCET ONCOLOGY, 2020, 21 (07): : 978 - 988
  • [8] Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Maddocks, Kami J.
    Duell, Johannes
    Gonzalez-Barca, Eva
    Jurczak, Wojciech
    Liberati, Anna Marina
    de Vos, Sven
    Nagy, Zsolt
    Obr, Ales
    Gaidano, Gianluca
    Abrisqueta, Pau
    Andre, Marc
    Dreyling, Martin
    Menne, Tobias F.
    Dirnberger-Hertweck, Maren
    Weirather, Johannes
    Ambarkhane, Sumeet
    Salles, Gilles
    BLOOD, 2020, 136
  • [9] Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
    Duell, Johannes
    Abrisqueta, Pau
    Andre, Marc
    Gaidano, Gianluca
    Gonzales-Barca, Eva
    Jurczak, Wojciech
    Kalakonda, Nagesh
    Liberati, Anna Marina
    Maddocks, Kami J.
    Menne, Tobias
    Nagy, Zsolt
    Tournilhac, Olivier
    Kuffer, Christian
    Bakuli, Abhishek
    Amin, Aasim
    Gurbanov, Konstantin
    Salles, Gilles
    REVISTA CHILENA DE LITERATURA, 2024, (109):
  • [10] Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
    Duell, Johannes
    Abrisqueta, Pau
    Andre, Marc
    Gaidano, Gianluca
    Gonzales-Barca, Eva
    Jurczak, Wojciech
    Kalakonda, Nagesh
    Liberati, Anna Marina
    Maddocks, Kami J.
    Menne, Tobias
    Nagy, Zsolt
    Tournilhac, Olivier
    Kuffer, Christian
    Bakuli, Abhishek
    Amin, Aasim
    Gurbanov, Konstantin
    Salles, Gilles
    HAEMATOLOGICA, 2024, 109 (02) : 553 - 566
12345